Skip to main content

Bayer to build €45 million greenhouse for insecticide research 

5th March 2018

Submitted by:

Andrew Warmington

Agrichemical giant Bayer is increasing its insecticide research capabilities by building a €45 million, 11,000m2 greenhouse at its Monheim site in North Rhine-Westphalia, Germany. 

It is Bayer’s largest single project in Mannheim in an investment programme that has totalled around €170 million over the past six years. 

The greenhouse – and adjoining 1,200m2 of laboratory space and 870m2 of office space – is designed to provide the best conditions for cultivating and testing over 30 different crop species and over 40 exotic pests and beneficial organisms.

With 133 compartments, a wide variety of climate conditions can be individually replicated, such as temperature, humidity, length of day, temperature curves and air filtration. It will be possible to conduct parallel studies on native and exotic crops using active ingredients currently in development and alternative technologies such as biological crop protection, plant breeding and beneficial-compatible combination strategies. 

Safeguarding food supply

“The new building will help us overcome one of the fundamental challenges of our times: safeguarding the global supply of food,” said Dr Dirk Backhaus, head of product supply and member of the executive committee of Bayer’s crop science division.


“We are living in times in which populism and political polarisation are endangering the acceptance
of modern science,” he added, citing recent emotionally charged campaigns such as the one against insecticidal substance classes such as neonicotinoids, the debate surrounding the reauthorisation of glyphosate and the media response to reports on the decline in insect populations in some parts of Germany. 

“Insects are of huge significance to Bayer due to their important role as pollinators of many crops,” Dr Backhaus said. 

Farmers around the world are increasingly facing new pest infestations and mounting resistance to currently available insecticides, while tighter regulations result in higher entry barriers for new insecticidal solutions. 

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington